Filing Details

Accession Number:
0001209191-19-024274
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-10 17:10:07
Reporting Period:
2019-04-08
Accepted Time:
2019-04-10 17:10:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426332 Ngm Biopharmaceuticals Inc NGM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606074 Peter Svennilson 1700 Owens Street
Suite 500
San Francisco CA 94158
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-08 20,000 $16.00 20,000 No 4 P Direct
Common Stock Acquisiton 2019-04-08 1,875,000 $16.00 2,350,957 No 4 P Indirect See Footnote
Common Stock Acquisiton 2019-04-08 13,093,134 $0.00 15,444,091 No 4 C Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See Footnote
No 4 C Indirect See Footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2019-04-08 12,000,000 $0.00 6,000,000 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2019-04-08 8,408,933 $0.00 4,204,467 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2019-04-08 2,377,334 $0.00 1,188,667 $0.00
Common Stock Series D Convertible Preferred Stock Disposition 2019-04-08 3,400,000 $0.00 1,700,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Includes 937,500 shares held directly by Ponoi Capital, LP ("Ponoi LP") and 937,500 shares held directly by Ponoi Capital II, LP ("Ponoi II LP"). The securities directly held by Ponoi LP are indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The securities directly held by Ponoi II LP are indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi LLC and Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC and Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
  2. Includes 100,000 shares beneficially owned by The Column Group GP, LP ("TCG GP"), 275,957 shares beneficially owned by The Column Group II, LP ("TCG II LP"), and 100,000 shares beneficially owned by The Column Group Management, LP ("TCGM LP"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. The securities directly held by TCG II LP are indirectly held by The Column Group II GP, LP ("TCG II GP") the general partner of TCG II LP. TCG II GP shares voting and dispositive power with respect to these shares. The individual managing partners of TCG GP, TCG II GP and TCGM LP are Peter Svennilson and David Goeddel, who may be deemed to have shared voting, investment and dispositive power with respect to these shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  3. Every two shares of Series A preferred stock, Series B preferred stock, Series C preferred stock and Series D preferred stock automatically converted into one share of common stock in connection with the closing of the issuer's initial public offering. These shares have no expiration date.
  4. Includes 11,103,333 shares beneficially owned by TCG LP and 1,989,801 shares beneficially owned by TCG II LP. The securities directly held by TCG LP are indirectly held by TCG GP, the general partner of TCG LP. TCG GP shares voting and dispositive power with respect to these shares. The individual managing partners of TCG GP are Peter Svennilson and David Goeddel, who may be deemed to have shared voting, investment and dispositive power with respect to these shares. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  5. Consists of 6,000,000 shares beneficially owned by The Column Group, LP ("TCG LP"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  6. Consists of 604,467 shares beneficially owned by TCG II LP and 3,600,000 shares beneficially owned by TCG LP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  7. Consists of 18,667 shares beneficially owned by TCG II LP and 1,170,000 shares beneficially owned by TCG LP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  8. Consists of 1,366,667 shares beneficially owned by TCG II LP and 333,333 shares beneficially owned by TCG LP. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.